Evoke Net Debt vs Total Current Liabilities Analysis

EVOK Stock  USD 4.10  0.02  0.49%   
Evoke Pharma financial indicator trend analysis is much more than just examining Evoke Pharma latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Evoke Pharma is a good investment. Please check the relationship between Evoke Pharma Net Debt and its Total Current Liabilities accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evoke Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Evoke Stock please use our How to buy in Evoke Stock guide.

Net Debt vs Total Current Liabilities

Net Debt vs Total Current Liabilities Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Evoke Pharma Net Debt account and Total Current Liabilities. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Evoke Pharma's Net Debt and Total Current Liabilities is -0.04. Overlapping area represents the amount of variation of Net Debt that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of Evoke Pharma, assuming nothing else is changed. The correlation between historical values of Evoke Pharma's Net Debt and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Debt of Evoke Pharma are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Net Debt i.e., Evoke Pharma's Net Debt and Total Current Liabilities go up and down completely randomly.

Correlation Coefficient

-0.04
Relationship DirectionNegative 
Relationship StrengthInsignificant

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.

Total Current Liabilities

Total Current Liabilities is an item on Evoke Pharma balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Evoke Pharma are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Most indicators from Evoke Pharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Evoke Pharma current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evoke Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Evoke Stock please use our How to buy in Evoke Stock guide.Selling General Administrative is expected to rise to about 11.6 M this year, although the value of Issuance Of Capital Stock will most likely fall to 0.00.

Evoke Pharma fundamental ratios Correlations

0.080.290.9-0.83-0.110.380.990.990.16-0.06-0.650.170.32-0.621.00.110.450.170.24-0.14-0.19-0.2-0.16-0.080.14
0.080.450.14-0.290.230.070.160.16-0.220.25-0.18-0.03-0.05-0.050.080.52-0.13-0.030.08-0.21-0.26-0.33-0.120.030.07
0.290.450.24-0.04-0.470.40.240.240.52-0.03-0.410.540.5-0.150.290.450.480.43-0.06-0.59-0.27-0.35-0.31-0.520.44
0.90.140.24-0.82-0.240.60.90.90.270.35-0.880.210.51-0.880.90.320.260.30.33-0.38-0.49-0.48-0.47-0.260.42
-0.83-0.29-0.04-0.82-0.28-0.24-0.9-0.90.23-0.190.540.26-0.010.57-0.83-0.110.070.19-0.23-0.110.080.050.01-0.240.08
-0.110.23-0.47-0.24-0.28-0.470.010.01-0.98-0.170.51-0.78-0.930.42-0.11-0.43-0.49-0.670.040.80.560.640.630.97-0.82
0.380.070.40.6-0.24-0.470.340.340.430.49-0.780.280.58-0.730.380.290.190.330.66-0.77-0.8-0.69-0.86-0.470.78
0.990.160.240.9-0.90.010.341.00.04-0.02-0.620.070.24-0.60.990.120.350.080.25-0.07-0.17-0.17-0.110.020.07
0.990.160.240.9-0.90.010.341.00.04-0.02-0.620.070.24-0.60.990.120.350.080.25-0.07-0.17-0.17-0.110.020.07
0.16-0.220.520.270.23-0.980.430.040.040.18-0.530.750.91-0.440.160.470.460.66-0.12-0.77-0.49-0.58-0.59-0.960.77
-0.060.25-0.030.35-0.19-0.170.49-0.02-0.020.18-0.6-0.090.28-0.66-0.060.45-0.550.120.2-0.41-0.53-0.51-0.62-0.280.48
-0.65-0.18-0.41-0.880.540.51-0.78-0.62-0.62-0.53-0.6-0.35-0.690.96-0.65-0.52-0.17-0.46-0.320.690.720.70.760.56-0.7
0.17-0.030.540.210.26-0.780.280.070.070.75-0.09-0.350.78-0.220.170.390.750.8-0.12-0.64-0.4-0.53-0.4-0.760.6
0.32-0.050.50.51-0.01-0.930.580.240.240.910.28-0.690.78-0.610.330.540.490.710.05-0.83-0.67-0.76-0.69-0.930.88
-0.62-0.05-0.15-0.880.570.42-0.73-0.6-0.6-0.44-0.660.96-0.22-0.61-0.62-0.43-0.05-0.38-0.360.580.690.650.740.46-0.63
1.00.080.290.9-0.83-0.110.380.990.990.16-0.06-0.650.170.33-0.620.110.450.170.25-0.15-0.21-0.21-0.17-0.080.14
0.110.520.450.32-0.11-0.430.290.120.120.470.45-0.520.390.54-0.430.110.040.38-0.08-0.6-0.57-0.59-0.48-0.590.55
0.45-0.130.480.260.07-0.490.190.350.350.46-0.55-0.170.750.49-0.050.450.040.640.05-0.35-0.19-0.26-0.15-0.40.3
0.17-0.030.430.30.19-0.670.330.080.080.660.12-0.460.80.71-0.380.170.380.64-0.17-0.57-0.44-0.53-0.48-0.660.6
0.240.08-0.060.33-0.230.040.660.250.25-0.120.2-0.32-0.120.05-0.360.25-0.080.05-0.17-0.38-0.61-0.48-0.590.040.38
-0.14-0.21-0.59-0.38-0.110.8-0.77-0.07-0.07-0.77-0.410.69-0.64-0.830.58-0.15-0.6-0.35-0.57-0.380.880.90.910.87-0.95
-0.19-0.26-0.27-0.490.080.56-0.8-0.17-0.17-0.49-0.530.72-0.4-0.670.69-0.21-0.57-0.19-0.44-0.610.880.950.950.64-0.89
-0.2-0.33-0.35-0.480.050.64-0.69-0.17-0.17-0.58-0.510.7-0.53-0.760.65-0.21-0.59-0.26-0.53-0.480.90.950.910.74-0.9
-0.16-0.12-0.31-0.470.010.63-0.86-0.11-0.11-0.59-0.620.76-0.4-0.690.74-0.17-0.48-0.15-0.48-0.590.910.950.910.68-0.92
-0.080.03-0.52-0.26-0.240.97-0.470.020.02-0.96-0.280.56-0.76-0.930.46-0.08-0.59-0.4-0.660.040.870.640.740.68-0.85
0.140.070.440.420.08-0.820.780.070.070.770.48-0.70.60.88-0.630.140.550.30.60.38-0.95-0.89-0.9-0.92-0.85
Click cells to compare fundamentals

Evoke Pharma Account Relationship Matchups

Evoke Pharma fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets6.4M9.4M10.6M11.9M7.1M10.1M
Other Current Liab1.9M6.0M506.9K528.1K(3.7M)(3.5M)
Total Current Liabilities2.0M7.5M1.4M1.7M3.0M2.3M
Total Stockholder Equity4.4M(3.2M)3.6M4.1M(2.6M)(2.5M)
Net Debt(5.5M)(2.8M)(4.1M)(4.7M)260.6K273.6K
Retained Earnings(85.7M)(98.9M)(107.4M)(115.6M)(123.4M)(117.3M)
Accounts Payable1.0M1.3M874.0K868.3K1.7M1.3M
Cash5.7M8.1M9.1M9.8M4.7M6.6M
Cash And Short Term Investments5.7M8.1M9.1M9.8M4.7M6.6M
Common Stock Total Equity1.5K1.7K2.4K2.7K3.1K3.2K
Common Stock Shares Outstanding1.9M177.0K223.5K262.0K278.6K264.7K
Liabilities And Stockholders Equity6.4M9.4M10.6M11.9M7.1M10.1M
Non Current Liabilities Total138.5K5.1M5.6M6.1M6.6M4.8M
Other Current Assets581.7K952.1K935.3K964.5K932.6K570.4K
Other Stockholder Equity90.1M95.7M111.0M119.7M120.9M75.9M
Total Liab2.0M12.6M7.0M7.8M9.6M6.5M
Total Current Assets6.2M9.3M10.6M11.7M6.8M10.0M
Common Stock2.4K2.7K3.3K334.0384.1364.89
Net Tangible Assets4.4M(3.2M)3.6M4.1M3.7M4.2M
Non Current Assets Total150.1K153.3K12.4K129.1K241.6K253.7K
Retained Earnings Total Equity(71.0M)(78.6M)(85.7M)(98.9M)(89.0M)(93.4M)
Capital Surpluse73.2M82.6M90.1M95.7M110.0M74.9M
Net Invested Capital4.4M1.9M8.6M9.1M2.4M2.3M
Net Working Capital4.2M1.7M9.2M10.1M3.8M6.1M
Capital Stock2.4K2.7K3.3K334.0300.6285.57

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Evoke Pharma is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Evoke Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Evoke Pharma Stock. Highlighted below are key reports to facilitate an investment decision about Evoke Pharma Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evoke Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Evoke Stock please use our How to buy in Evoke Stock guide.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evoke Pharma. If investors know Evoke will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evoke Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(10.13)
Revenue Per Share
7.792
Quarterly Revenue Growth
0.698
Return On Assets
(0.34)
Return On Equity
(3.50)
The market value of Evoke Pharma is measured differently than its book value, which is the value of Evoke that is recorded on the company's balance sheet. Investors also form their own opinion of Evoke Pharma's value that differs from its market value or its book value, called intrinsic value, which is Evoke Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evoke Pharma's market value can be influenced by many factors that don't directly affect Evoke Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evoke Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evoke Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evoke Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.